New Study Supports the Combination of an Excimer Laser and an Oral JAK Inhibitor in Non-segmental Vitiligo September 22, 2025
Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc. and Sanofi) Scores Positive CHMP Opinion for CSU in Europe September 22, 2025
EADV 2025 News: Evommune, Inc.’s EVO756 Shows Robust and Rapid Improvement in CindU Patients September 20, 2025
From the Podium to Your Practice: Dr. Christopher Bunick Discusses New Real-world Safety Data on Upadacitinib (Rinvoq, AbbVie) in AD September 19, 2025
Breaking News: U.S. FDA Approves Ruxolitinib Cream 1.5% (Opzelura, Incyte) for Kids Age 2 and up With AD September 18, 2025